UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

The New England journal of medicine, 2019-08, Vol.381 (7), p.614-625

2019

Volltextzugriff (PDF)

Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis

Multiple sclerosis, 2018-08, Vol.24 (9), p.1205-1211

2018

Volltextzugriff (PDF)

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis

Multiple sclerosis, 2018-10, Vol.24 (12), p.1617-1626

2018

Volltextzugriff (PDF)

External validation of a clinical prediction model in multiple sclerosis

Multiple sclerosis, 2023-02, Vol.29 (2), p.261-269

2023

Volltextzugriff (PDF)

Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

Multiple sclerosis, 2022-10, Vol.28 (11), p.1752-1761

2022

Volltextzugriff (PDF)

Making the Discrimination in the Walking Parameters of Individuals with Multiple Sclerosis and Parkinson’s Disease with Machine Learning

Türk nöroloji dergisi, 2023-12, Vol.29 (4), p.277-281

2023

Volltextzugriff (PDF)

Long-term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder (1494)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking Scale

Multiple sclerosis journal - experimental, translational and clinical, 2017-09, Vol.3 (3), p.2055217317728740-2055217317728740

2017

Volltextzugriff (PDF)

Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depression

Arquivos de neuro-psiquiatria, 2022-02, Vol.80 (2), p.168-172

2022

Volltextzugriff (PDF)

Inositol‐requiring enzyme‐1 regulates phosphoinositide signaling lipids and macrophage growth

EMBO reports, 2020-12, Vol.21 (12), p.e51462-n/a

2020

Volltextzugriff (PDF)

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

The New England journal of medicine, 2019-08, Vol.381 (7), p.614-625

2019

Volltextzugriff (PDF)

Psychiatric symptoms in patients with multiple sclerosis

General hospital psychiatry, 2013-03, Vol.35 (2), p.134-140

2013

Volltextzugriff (PDF)

Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase

Multiple sclerosis journal - experimental, translational and clinical, 2024-04, Vol.10 (2), p.20552173241247182-20552173241247182

2024

Volltextzugriff (PDF)

Relationship of personality traits with stigmatization, depression, and quality of life in patients with multiple sclerosis

Neurology Asia, 2023-12, Vol.28 (4), p.1031-1040

2023

Volltextzugriff (PDF)

Restless Leg Syndrome and Sleep Quality in Lumbar Radiculopathy Patients

Behavioural neurology, 2014-01, Vol.2014 (2014), p.1-5

2014

Volltextzugriff (PDF)

004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A2-A2

2021

Volltextzugriff (PDF)

NSAIDs medication for headache as the presenting symptom with migraine and COVID‐19

Journal of experimental and clinical medicine, 2021-08, Vol.38 (4), p.645-648

TÜRKDÖNMEZ, Elif

2021

Volltextzugriff (PDF)

Effect of self-acupressure on fatigue in patients with multiple sclerosis

Complementary therapies in clinical practice, 2022-05, Vol.47, p.101572, Article 101572

2022

Volltextzugriff (PDF)

Scholarship programs as public diplomacy tool and implementations in Turkic council countries

Bilig (Ankara), 2021-12, Vol.2021 (96), p.229-253

2021

Volltextzugriff (PDF)

A year with the fear of COVID-19 in multiple sclerosis patients: Examination of depression, sleep quality and quality of life before and after the pandemic

Multiple sclerosis and related disorders, 2022-01, Vol.57, p.103370-103370, Article 103370

2022

Volltextzugriff (PDF)

Relationship between stigma and symptom burden in patients with multiple sclerosis

Neurology Asia, 2023-06, Vol.28 (2), p.359-366

2023

Volltextzugriff (PDF)

Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis

Clinical neurology and neurosurgery, 2023-01, Vol.224, p.107528-107528, Article 107528

2023

Volltextzugriff (PDF)

1 – 25 von 287

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(179)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Life Sciences & Biomedicine
(154)
Neurosciences & Neurology
(94)
Clinical Neurology
(87)
Humans
(86)
Multiple Sclerosis
(83)
Female
(61)
Male
(60)
Adult
(50)
Middle Aged
(32)
Neurosciences
(31)
Patients
(26)
Surgery
(21)
Magnetic Resonance Imaging
(20)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(19)
Recurrence
(19)
Risk Factors
(17)
General & Internal Medicine
(16)
Treatment Outcome
(16)
Disease Progression
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis

External validation of a clinical prediction model in multiple sclerosis

Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study

Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

Making the Discrimination in the Walking Parameters of Individuals with Multiple Sclerosis and Parkinson’s Disease with Machine Learning

Long-term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder (1494)

Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking Scale

Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depression

Inositol‐requiring enzyme‐1 regulates phosphoinositide signaling lipids and macrophage growth

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

Psychiatric symptoms in patients with multiple sclerosis

Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase

Relationship of personality traits with stigmatization, depression, and quality of life in patients with multiple sclerosis

Restless Leg Syndrome and Sleep Quality in Lumbar Radiculopathy Patients

004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis

NSAIDs medication for headache as the presenting symptom with migraine and COVID‐19

Effect of self-acupressure on fatigue in patients with multiple sclerosis

Scholarship programs as public diplomacy tool and implementations in Turkic council countries

A year with the fear of COVID-19 in multiple sclerosis patients: Examination of depression, sleep quality and quality of life before and after the pandemic

Relationship between stigma and symptom burden in patients with multiple sclerosis

Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis

Suchergebnisse filtern